FrancophonIA/ELRC3.0 huggingface dataset:
English: Concomitant use of etravirine with nevirapine may cause a significant decrease in the plasma concentrations of etravirine and loss of therapeutic effect of etravirine.
Slovenian: Pri sočasni uporabi etravirina in nevirapina se lahko pomembno zmanjša koncentracija etravirina v plazmi in izgubi njegov terapevtski učinek.
English: Viramune tablets contain lactose (milk sugar).
Slovenian: Tableta Viramune vsebuje laktozo (mlečni sladkor).
English: Appropriate doses for hormonal contraceptives (oral or other forms of application) other than DMPA in combination with Viramune have not been established with respect to safety and efficacy.
Slovenian: Varnost in učinkovitost ustreznih odmerkov hormonskih kontraceptivov (za peroralno jemanje ali druge načine uporabe) v kombinaciji z zdravilom Viramune, razen DMPA, nista raziskani.
English: 3 for men.
Slovenian: Ali 4.
English: Some patients have reported the occurrence of remnants in faeces which may resemble intact tablets.
Slovenian: Nekateri bolniki so v blatu opazili preostanke, ki so bili podobni nespremenjenim tabletam.
English: The analysis of these samples of patients receiving Viramune immediate-release twice daily or Viramune prolonged-release once daily in combination with tenofovir and emtricitabine showed that isolates from 50 patients contained resistance mutations expected with a nevirapine-based regimen.
Slovenian: Analiza vzorcev bolnikov, ki so jemali dvakrat na dan zdravilo Viramune s takojšnjim sproščanjem ali enkrat na dan zdravilo Viramune s podaljšanim sproščančjem v kombinaciji s tenofovirjem in emtricitabinom, je pokazala, da so vsebovali izolati 50 bolnikov z odpornostjo povezane mutacije, ki so pri zdravljenju z nevirapinom pričakovane.
English: NET Cmax  0.84 (0.73 - 0.97)
Slovenian: Cmax NET  0,84 (0,73-0,97)
English: Viramune prolonged-release tablets or parts of tablets may occasionally be passed and seen in the stool (faeces).
Slovenian: Tablete zdravila Viramune s podaljšanim sproščanjem ali delci tablet se lahko včasih izločijo in jih lahko opazite v blatu.
English: Due to the metabolic pathway of raltegravir no interaction is expected.
Slovenian: Zaradi raltegravirjeve presnovne poti predvidoma ne prihaja do interakcije.
English: EXP To be used within 6 months after opening the bottle
Slovenian: EXP Uporabno 6 mesecev po odprtju plastenke
English: Absolute bioavailability in 12 healthy adults following single-dose administration was 93  9 % (mean SD) for a 50 mg tablet and 91  8 % for an oral solution.
Slovenian: Absolutna biološka uporabnost je bila pri 12 zdravih odraslih po enkratnem odmerku 93  9 % (srednja SD) za tableto po 50 mg in 91  8 % za peroralno raztopino.
English: Viramune tablets and oral suspension have been shown to be comparably bioavailable and interchangeable at doses up to 200 mg.
Slovenian: Zdravili Viramune tablete in peroralna suspenzija sta primerljivo biološko uporabna in v odmerkih do 200 mg zamenljiva.
English: The first 18 weeks of therapy with nevirapine are a critical period which requires close monitoring of patients to disclose the potential appearance of severe and life-threatening skin reactions (including cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)) and serious hepatitis/hepatic failure.
Slovenian: Prvih 18 tednov zdravljenja z nevirapinom je kritično obdobje, v katerem moramo bolnike skrbno spremljati, da bi lahko odkrili morebitne hude in življenjsko nevarne kožne reakcije (npr. Stevens-Johnsonov sindrom (SJS) in toksično epidermalno nekrolizo (TEN)) in resen hepatitis oz. jetrno odpoved.
English: According to paediatric dose recommendations Viramune 400 mg prolonged-release tablets can be also taken by children, following the adult dosing schedule, if they
Slovenian: V skladu s priporočili za odmerjanje zdravila lahko zdravilo Viramune 400 mg tablete s podaljšanim sproščanjem po shemi odmerjanja za odrasle jemljejo tudi otroci, če
English: Tenofovir plasma levels remain unchanged when co-administered with nevirapine.
Slovenian: Ravni tenofovirja v plazmi ostanejo med sočasnim dajanjem z nevirapinom nespremenjene.
English: If ASAT or ALAT > 2.5 ULN before or during treatment, then liver tests should be monitored more frequently during regular clinic visits.
Slovenian: Če je raven ASAT ali ALAT pred zdravljenjem ali med njim povečana na ≥ 2,5-kratno zgornjo mejno vrednost, je treba jetrne preiskave ob rednih kontrolnih pregledih opravljati pogosteje.
English: This includes some cases of inflammation of the liver (hepatitis), which can be sudden and intense (fulminant hepatitis), and liver failure, which can be both fatal.
Slovenian: Med njimi nekaj primerov vnetja jeter (hepatitisa), ki je lahko nenadno in intenzivno (fulminantni hepatitis), in jetrne odpovedi, ki se oba lahko končata s smrtjo.
English: Nervous system disorders Common headache
Slovenian: Bolezni živčevja pogosti glavobol
English: Viramune must not be readministered to patients who have required permanent discontinuation for clinical hepatitis due to nevirapine.
Slovenian: Zdravila Viramune ne smemo ponovno dajati bolnikom, katerim smo ga morali dokončno ukiniti zaradi klinične oblike hepatitisa, ki jo je povzročil nevirapin.
English: In a mass balance/excretion study in eight healthy male volunteers dosed to steady state with nevirapine 200 mg given twice daily followed by a single 50 mg dose of 14C-nevirapine, approximately 91.4  10.5 % of the radiolabelled dose was recovered, with urine (81.3  11.1 %) representing the primary route of excretion compared to faeces (10.1  1.5 %).
Slovenian: V raziskavi o masni bilanci in izločanju pri osmih zdravih prostovoljcih, ki so do stanja dinamičnega ravnovesja prejemali odmerke nevirapina po 200 mg 2-krat na dan, nato enkratni odmerek po 50 mg 14C-nevirapina, se je izločilo približno 91,4  10,5 % radioaktivno označenega odmerka, pri čemer je bila glavna pot izločanja s sečem (81,3  11,1 %) v primerjavi z blatom (10,1  1,5 %).
English: At week 48, mean change from baseline in CD4 cell count was 184 cells/mm
Slovenian: Po 48 tednih je bila srednja sprememba izhodiščnega števila CD4 184 celic/mm
English: Viramune is also supplied as 200 mg tablets for older children and adults.
Slovenian: Zdravilo Viramune je na voljo tudi v obliki tablet po 200 mg za starejše otroke in odrasle.
English: Nevirapine AUC  1.20 Nevirapine Cmax  1.20
Slovenian: AUC nevirapina  1,20 Cmax nevirapina  1,20
English: In this 48week study no unexpected safety findings were observed in either dosing group.
Slovenian: V tej 48-tedenski raziskavi v nobeni od skupin z različnim odmerjanjem niso poročali o nepričakovanih izsledkov, povezanih z varnostjo.
English: Other enzymes may be involved in the metabolism.
Slovenian: Pri presnovi lahko sodelujejo tudi drugi encimi.
English: Patients should be instructed that a major toxicity of nevirapine is rash.
Slovenian: Bolnikom je treba povedati, da je glavni toksični pojav pri nevirapinu izpuščaj.
English: Children less than three years old.
Slovenian: Otroci, mlajši od 3 let
English: INFORMATION IN BRAILLE Viramune 50 mg/5 ml
Slovenian: PODATKI V BRAILLOVI PISAVI Viramune 50 mg/5 ml
English: Patients developing signs or symptoms of hepatitis, severe skin reaction or hypersensitivity reactions must discontinue nevirapine and seek medical evaluation immediately.
Slovenian: Bolniki, pri katerih se razvijejo znaki ali simptomi hepatitisa, huda kožna reakcija ali preobčutljivostne reakcije, morajo prenehati jemati nevirapin, njihovo stanje pa mora nemudoma oceniti zdravnik.
English: Skin and subcutaneous tissues
Slovenian: Koža in podkožje
English: Each tablet contains 318 mg of lactose (as monohydrate).
Slovenian: Ena tableta vsebuje 318 mg laktoze (v obliki monohidrata).
English: Tenofovir 300 mg QD
Slovenian: Tenofovir 300 mg na dan
English: What Viramune is and what it is used for What do you need to know before you take Viramune How to take Viramune
Slovenian: Kaj je zdravilo Viramune in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Viramune Kako jemati zdravilo Viramune Možni neželeni učinki
English: Depending on resistance testing results, an etravirine-containing regimen may be used subsequently.
Slovenian: Na podlagi preizkusa odpornosti lahko v nadaljevanju uporabimo režim zdravljenja, ki zajema etravirin.
English: The inducing effect may persist for at least 2 weeks after cessation of treatment with St. John‘s Wort.
Slovenian: Indukcija lahko traja najmanj dva tedna po prekinitvi jemanja šentjanževke.
English: The study randomly assigned 460 adults who were taking two nucleoside reverse-transcriptase inhibitors and at least one PI and whose plasma HIV-1 RNA levels had been less than 200 c/ml for at least the previous six months to switch from the PI to Viramune (155 patients), efavirenz (156), or abacavir (149).
Slovenian: V študijo so naključno sprejeli 460 odraslih, ki so jemali dva nukleozidna zaviralca reverzne transkriptaze in najmanj enega zaviralca proteaze, in pri kateerih je bila plazemska koncentracija HIV1 RNA manj kot 200 kopij/ml vsaj preteklih šest mesecev pred zamenjavo zaviralca proteaze za zdravilo Viramune (155 bolnikov), efavirenz (156) ali abakavir (149).
English: Immune Reactivation Syndrome: In HIV-infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic pathogens may arise and cause serious clinical conditions, or aggravation of symptoms.
Slovenian: Sindrom imunske reaktivacije: pri s HIV okuženih bolnikih s hudo imunsko pomanjkljivostjo lahko ob uvedbi kombiniranega protiretrovirusnega zdravljenja (CART - "combination antiretroviral therapy") nastane vnetna reakcija na asimptomatične ali rezidualne oportunistične patogene in povzroči resna klinična stanja ali poslabšanje simptomov.
English: No dose adjustment is necessary in patients with mild to moderate hepatic impairment (see sections 4.4 and 5.2).
Slovenian: Bolnikom z blago do zmerno jetrno okvaro odmerka ni potrebno prilagajati (glejte poglavji 4.4 in 5.2).
English: Overall, there was a comparable incidence of symptomatic hepatic events among men and women enrolled in VERxVE.
Slovenian: V študiji VERxVE je bila skupna pojavnost simptomatskih jetrnih dogodkov pri moških in ženskah primerljiva.
English: Additionally, when postmenopausal hormone therapy is used during administration of nevirapine, its therapeutic effect should be monitored.
Slovenian: Pri uporabi hormonskega nadomestnega zdravljenja v pomenopavzi, je treba med jemanjem nevirapina spremljati njihov terapevtski učinek.
English: The majority of rashes associated with nevirapine occur within the first 6 weeks of initiation of therapy.
Slovenian: Izpuščaj, ki je povezan z nevirapinom, se večinoma pojavi v prvih 6 tednih po začetku zdravljenja.
English: 150 mg/m2 QD) produced geometric mean or mean trough nevirapine concentrations between 46 µg/ml (as targeted from adult data).
Slovenian: 150 mg/m2 vsak dan) je bila geometrična sredina koncentracije nevirapina ali njegova najmanjša srednja koncentracija 4 -6 µg/ml (ciljna glede na podatke za odrasle).
English: There is no known antidote for nevirapine overdose.
Slovenian: Za prevelik odmerek nevirapina ni znanega antidota.
English: Viramune should be administered by physicians who are experienced in the treatment of HIV infection.
Slovenian: Zdravilo Viramune lahko predpisujejo zdravniki, ki imajo izkušnje z zdravljenjem okužbe s HIV.
English: Nevirapine Cmax  1.24 compared to historical controls.
Slovenian: Cmax nevirapina  1,24 v primerjavi s prejšnjimi, kontrolnimi vrednostmi
English: Absorption: Nevirapine is readily absorbed (> 90 %) after oral administration in healthy volunteers and in adults with HIV-1 infection.
Slovenian: Absorpcija: nevirapin se po peroralnem dajanju pri zdravih prostovoljcih in odraslih s HIV-1 okuženih osebah hitro in z lahkoto absorbira (> 90 %).
English: Asymptomatic elevations of liver enzymes are frequently described and are not necessarily a contraindication to use nevirapine.
Slovenian: Pogosto opisujejo nesimptomatično povečanje jetrnih encimov, ki pa ni vedno kontraindikacija za nevirapin.
English: It is important that the entire measured dose of Viramune oral suspension is administered.
Slovenian: Pomembno je, da vzame bolnik vso odmerjeno količino peroralne suspenzije Viramune.
English: LIST OF EXCIPIENTS Excipients: includes lactose (see leaflet for further information)
Slovenian: SEZNAM POMOŽNIH SNOVI Pomožne snovi: vsebuje laktozo (za podrobne podatke glejte priloženo navodilo).
English: This is assisted by the use of the supplied dispensing syringe.
Slovenian: Pri tem je v pomoč priložena brizga za dajanje.
English: Week 48 (mean) n=407
Slovenian: Po 48 tednih (srednja vrednost) n = 407
English: If Viramune has been prescribed for your child, please note that all information in this leaflet is addressed to your child (in this case please read “your child” instead of “you”).
Slovenian: Če je bilo zdravilo Viramune predpisano vašemu otroku, se vse informacije v tem navodilu za uporabo nanašajo na vašega otroka (v tem primeru prosim berite "vaš otrok" namesto "vi").
English: Viramune oral suspension is in a liquid suspension form and should only be taken by mouth.
Slovenian: Peroralna suspenzija Viramune je tekoča suspenzija in jo je vedno treba pogoltniti.
English: Results of a 48-week analysis of the South African study BI 1100.1368 confirmed that the 4/7 mg/kg and 150 mg/m2 nevirapine dose groups were well tolerated and effective in treating antiretroviral naive paediatric patients.
Slovenian: Izsledki analize podatkov iz 48-tedenskega obdobja v južnoafriški raziskavi BI 1100.1368 so potrdili, da je prenašanje odmerkov nevirapina po 4/7 mg/kg in 150 mg/m2 dobro in da so bili učinkoviti v zdravljenju prvič zdravljenih pediatričnih bolnikov.
English: For smaller children smaller prolonged-release tablets or an oral suspension liquid form are available.
Slovenian: Za mlajše otroke so na voljo tablete s podaljšanim sproščanjem v nižji jakosti ali peroralna suspenzija.
English: High density polyethylene (HDPE) plastic bottle, with a plastic cap and an induction foil seal liner.
Slovenian: Plastenka iz polietilena velike gostote (HDPE) s plastično zaporko in indukcijsko pečatno linijsko folijo.
English: INFORMATION IN BRAILLE Viramune 200 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Viramune 200 mg
English: Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse reactions.
Slovenian: Bolnike s kroničnim hepatitisom B ali C, ki prejemajo kombinirano protivirusno zdravljenje, spremlja povečano tveganje hudih neželenih učinkov na jetra, ki so lahko tudi smrtno nevarni.
English: If you experience fatigue you should avoid potentially hazardous tasks such as driving or using any tools or machines.
Slovenian: Če boste utrujeni, se morate izogibati dejavnostim, ki so lahko nevarne, na primer vožnji ali uporabi kakršnihkoli orodij ali strojev.
English: Viramune prolonged-release tablets are only to be used for children three years of age and above.
Slovenian: Zdravilo Viramune tablete s podaljšanim sproščanjem je dovoljeno uporabljati samo pri triletnih in starejših otrocih.
English: In single dose, parallel group bioavailability studies (studies 1100.1517 and 1100.1531), the Viramune 50 and 100 mg prolonged-release tablets exhibited extended release characteristics of prolonged absorption and lower maximal concentrations, similar to the findings when a 400 mg prolongedrelease tablet was compared to the Viramune immediate-release 200 mg tablet.
Slovenian: V dveh študijah (1100.1517 in 1100.1531) o bioekvivalenci enkratnih odmerkov pri vzporednih skupinah preskušancev sta kazala zdravilo Viramune 50 mg in 100 mg tablete s podaljšanim sproščanjem značilnosti podaljšanega sproščanja, in sicer podaljšano absorpcijo in manjše največje koncentracije, podobno kot so pokazali izsledki primerjave med 400 mg tableto s podaljšanim sproščanjem in zdravilom Viramune 200 mg tablete s takojšnjim sproščanjem.
English: Week 48 (mean) n=419
Slovenian: Po 48 tednih (srednja vrednost) n = 419
English: Following multiple doses, nevirapine peak concentrations appear to increase linearly in the dose range of 200 to 400 mg/day.
Slovenian: Kaže, da se po večkratnih odmerkih nevirapinove največje koncentracije v razponu 200 do 400 mg/dan večajo linearno.
English: Viramune prolonged-release n=508*
Slovenian: Zdravilo Viramune s podaljšanim sproščanjem n=508*
English: However, the risk of any hepatic event continues past this period and monitoring should continue at frequent intervals.
Slovenian: Toda ogroženost zaradi jetrnih dogodkov traja še po tem obdobju, zato je še potrebno nadaljnje pogosto spremljanje.
English: Rare (may affect up to 1 in 1000 people): - inflammation of the liver (hepatitis) - decreased numbers of red blood cells (anaemia)
Slovenian: Redki (pojavijo se lahko pri največ 1 do 1.000 bolnikov): - vnetje jeter (hepatitis) - zmanjšanje števila rdečih krvničk (anemija).
English: For younger children starting from birth an oral suspension is available.
Slovenian: Za mlajše otroke, od novorojenčkov naprej, je na voljo peroralna suspenzija.
English: There is not enough evidence to substantiate that the absence of an increased risk for toxicity seen in pretreated women initiating nevirapine with an undetectable viral load (less than 50 copies/ml of HIV-1 in plasma) and CD4 cell counts above 250 cells/mm
Slovenian: Na voljo ni dovolj dokazov za trditev, da odsotnost povečanega tveganja za toksičnost pri že zdravljenih ženskah, ki imajo ob uvedbi nevirapina neizmerljivo virusno breme (manj kot 50 kopij/ml HIV-1 v plazmi) in število celic CD4 nad 250 celic/mm
English: Clinical hepatitis reported as clinical adverse event occurred in 10 (2.6 %) and 2 (0.5 %) patients in the nevirapine twice daily and efavirenz groups respectively.
Slovenian: Klinični hepatitis, o katerem so poročali kot o kliničnem neželenem učinku, je imelo 10 bolnikov (2,6 %) v skupini, ki je jemala nevirapin dvakrat na dan, in 2 bolnika (0,5 %) v skupini, ki je jemala efavirenz.
English: Two new substitutions on codons previously associated with nevirapine resistance were observed: one patient with Y181I in the Viramune prolonged-release group and one patient with Y188N in the Viramune immediate-release group; resistance to nevirapine was confirmed by phenotype.
Slovenian: Odkrili so dve novi substituciji na kodonih, ki so jih že prej povezovali z odpornostjo proti nevirapinu: en bonik z Y181I v skupini z zdravilom Viramune s podaljšanim sproščanjem in en bolnik z Y188N v skupini z zdravilom Viramune s takojšnjim sproščanjem.
English: The frequencies estimated are based on pooled clinical study data for adverse reactions considered related to Viramune treatment.
Slovenian: Ocena pogostnosti temelji na zbirnih podatkih iz kliničnih študij o neželenih učinkih, za katere so menili, da so povezani z zdravljenjem zdravilom Viramune.
English: ANTITHROMBOTICS Warfarin
Slovenian: ANTITROMBOTIKI Varfarin
English: 3 in adult males) at the initiation of nevirapine therapy are associated with a greater risk of hepatic adverse reactions if the patient has detectable plasma HIV-1 RNA - i.e. a concentration ≥ 50 copies/ml - at the initiation of nevirapine.
Slovenian: 3 pri odraslih moških) na začetku zdravljenja z nevirapinom povečano tveganje neželenih učinkov na jetra, če imajo v plazmi izmerljivo raven HIV-1 RNA - tj. če je ob uvajanju nevirapina koncentracija ≥ 50 kopij/ml.
English: Prednisone should not be used to treat a rash related to Viramune.
Slovenian: Prednizona ne smemo uporabljati za zdravljenje izpuščaja, povezanega z jemanjem zdravila Viramune.
English: Patients who interrupt nevirapine dosing for more than 7 days should restart the recommended dosing regimen using the two week lead-in period.
Slovenian: Bolniki, ki prekinejo jemanje nevirapina za več kot 7 dni, ga morajo nadaljevati po priporočeni shemi odmerjanja in upoštevati dvotedensko uvajalno obdobje.
English: Cobicistat, a cytochrome P450 3A inhibitor significantly inhibits hepatic enzymes, as well as other metabolic pathways.
Slovenian: Kobicistat je zaviralec citokroma P450 (CYP) 3A, ki znatno zavira jetrne encime in tudi druge presnovne poti.
English: Peak plasma nevirapine concentrations of 2  0.4 µg/ml (7.5 µM) were attained by 4 hours following a single 200 mg dose.
Slovenian: Največje koncentracije nevirapina v plazmi (2  0,4 µg/ml oz. 7,5 µM) so izmerili 4 ure po dajanju enkratnega odmerka po 200 mg.
English: The pharmacokinetics of nevirapine has been studied in a single dose study (study 1100.1485) of Viramune prolonged-release in 17 healthy volunteers.
Slovenian: Farmakokinetiko nevirapina so proučevali v študiji (študija 1100.1485) z enkratnim odmerkom zdravila Viramune s podaljšanim sproščanjem, v kateri je sodelovalo 17 zdravih prostovoljcev.
English: For patients less than 3 years and for all other age groups, an immediate-release oral suspension dosage form is available (please refer to the respective Summary of Product Characteristics).
Slovenian: Za bolnike, ki so mlajši od 3 let, in vse druge starostne skupine je na voljo peroralna suspenzija s takojšnjim sproščanjem (prosimo, poglejte v ustrezen Povzetek glavnih značilnosti zdravila).
English: The overall percentage of treatment responders observed in study 1100.1486 (including lead-in phase), regardless of the formulation is 793/1,068 = 74.3 %.
Slovenian: Skupni delež bolnikov, ki so se v študiji 1100.1486 (vključno z uvajalnim obdobjem) odzivali na zdravljenje je 793/1.068 = 74,3 % ne glede na farmacevtsko obliko zdravila.
English: Itraconazole Cmax  0.62
Slovenian: Cmax itrakonazola  0,62
English: Currently available data on pregnant women indicate no malformative or foeto/ neonatal toxicity.
Slovenian: Razpoložljivi podatki pri nosečnicah ne kažejo na anomalije ali okvare pri zarodku oziroma novorojenčku zaradi toksičnosti.
English: The safety and efficacy of Viramune has not been established in patients with significant underlying liver disorders.
Slovenian: Varnost in učinkovitost zdravila Viramune pri bolnikih s hujšimi jetrnimi motnjami nista bili dokazani.
English: These are supplied in the package leaflets for those medicines.
Slovenian: So v navodilih za uporabo teh zdravil.
English: Viramune prolonged-release tablets may be dosed based on a patient's weight or body surface area (BSA).
Slovenian: Zdravilo Viramune tablete s podaljšanim sproščanjem lahko odmerjamo na podlagi bolnikove telesne mase ali telesne površine.
English: Amprenavir AUC  0.89 (0.77
Slovenian: AUC amprenavirja  0,89 (0,77
English: Your child's doctor will continually check your child's age, weight or body surface area to ensure the correct dose.
Slovenian: Otrokov zdravnik bo redno preverjal otrokovo starost, telesno maso ali površino, da bi zagotovil, da otrok prejema pravilen odmerek.
English: For patients already on a regimen of Viramune immediate-release twice daily who switch to Viramune prolonged-release once daily there is no need for a change in their monitoring schedule.
Slovenian: Bolnikom, ki že jemljejo zdravilo Viramune s takojšnjim sproščanjem dvakrat na dan, ob prehodu na zdravljenje z zdravilom Viramune s podaljšanim sproščanjem, ki ga bodo jemali enkrat na dan, ni treba spreminjati sheme spremljanja zdravljenja.
English: The effects of gender on the pharmacokinetics of Viramune prolonged-release have been investigated in study 1100.1486.
Slovenian: Vpliv spola na farmakokinetiko zdravila Viramune s podaljšanim sproščanjem so proučevali v študiji 1100.1486.
English: - The other ingredients are lactose (as monohydrate), hypromellose, iron oxide yellow and magnesium stearate.
Slovenian: - Druge sestavine zdravila so: laktoza (v obliki monohidrata), hipromeloza, rumeni železov oksid in magnezijev stearat.
English: Viramune prolonged-release tablets contain lactose (milk sugar).
Slovenian: Zdravilo Viramune tablete s podaljšanim sproščanjem vsebuje laktozo (mlečni sladkor).